CN112370526A - 一种用于癌症光热治疗的金纳米棒合成方法 - Google Patents
一种用于癌症光热治疗的金纳米棒合成方法 Download PDFInfo
- Publication number
- CN112370526A CN112370526A CN202011238200.2A CN202011238200A CN112370526A CN 112370526 A CN112370526 A CN 112370526A CN 202011238200 A CN202011238200 A CN 202011238200A CN 112370526 A CN112370526 A CN 112370526A
- Authority
- CN
- China
- Prior art keywords
- solution
- nabh
- gold nanorods
- ctab
- concentration
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 title claims abstract description 71
- 206010028980 Neoplasm Diseases 0.000 title claims abstract description 34
- 201000011510 cancer Diseases 0.000 title claims abstract description 29
- 238000007626 photothermal therapy Methods 0.000 title claims abstract description 14
- 238000001308 synthesis method Methods 0.000 title claims abstract description 10
- 239000000243 solution Substances 0.000 claims abstract description 106
- LZZYPRNAOMGNLH-UHFFFAOYSA-M Cetrimonium bromide Chemical compound [Br-].CCCCCCCCCCCCCCCC[N+](C)(C)C LZZYPRNAOMGNLH-UHFFFAOYSA-M 0.000 claims abstract description 29
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims abstract description 20
- 238000003756 stirring Methods 0.000 claims abstract description 14
- 239000012279 sodium borohydride Substances 0.000 claims abstract description 12
- 229910000033 sodium borohydride Inorganic materials 0.000 claims abstract description 12
- 239000007864 aqueous solution Substances 0.000 claims abstract description 10
- 229960005070 ascorbic acid Drugs 0.000 claims abstract description 10
- 239000002244 precipitate Substances 0.000 claims abstract description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 8
- 239000011668 ascorbic acid Substances 0.000 claims abstract description 7
- 235000010323 ascorbic acid Nutrition 0.000 claims abstract description 7
- 101710134784 Agnoprotein Proteins 0.000 claims abstract description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims abstract description 4
- 239000008363 phosphate buffer Substances 0.000 claims abstract description 4
- 239000011780 sodium chloride Substances 0.000 claims abstract description 4
- 239000006228 supernatant Substances 0.000 claims abstract description 4
- 238000000034 method Methods 0.000 claims description 28
- SQGYOTSLMSWVJD-UHFFFAOYSA-N silver(I) nitrate Inorganic materials [Ag+].[O-]N(=O)=O SQGYOTSLMSWVJD-UHFFFAOYSA-N 0.000 claims description 12
- 239000011259 mixed solution Substances 0.000 claims description 8
- 229910004042 HAuCl4 Inorganic materials 0.000 claims description 5
- 238000002360 preparation method Methods 0.000 claims description 5
- 235000000069 L-ascorbic acid Nutrition 0.000 claims description 3
- 239000002211 L-ascorbic acid Substances 0.000 claims description 3
- 230000015572 biosynthetic process Effects 0.000 claims description 3
- 238000005119 centrifugation Methods 0.000 claims description 3
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 claims description 3
- 239000002953 phosphate buffered saline Substances 0.000 claims description 3
- 238000003786 synthesis reaction Methods 0.000 claims description 3
- 238000010189 synthetic method Methods 0.000 claims 2
- 239000011521 glass Substances 0.000 abstract description 2
- 238000010521 absorption reaction Methods 0.000 description 9
- 230000002194 synthesizing effect Effects 0.000 description 9
- 238000011282 treatment Methods 0.000 description 9
- 239000013078 crystal Substances 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- 239000002105 nanoparticle Substances 0.000 description 5
- 238000006243 chemical reaction Methods 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 230000031700 light absorption Effects 0.000 description 4
- 238000002371 ultraviolet--visible spectrum Methods 0.000 description 4
- 238000010586 diagram Methods 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 229910052737 gold Inorganic materials 0.000 description 3
- 239000010931 gold Substances 0.000 description 3
- 239000002245 particle Substances 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 239000003223 protective agent Substances 0.000 description 3
- 230000005855 radiation Effects 0.000 description 3
- 238000001356 surgical procedure Methods 0.000 description 3
- 238000007669 thermal treatment Methods 0.000 description 3
- 238000003917 TEM image Methods 0.000 description 2
- 229960000800 cetrimonium bromide Drugs 0.000 description 2
- 230000001427 coherent effect Effects 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 239000002086 nanomaterial Substances 0.000 description 2
- 230000003287 optical effect Effects 0.000 description 2
- 230000010355 oscillation Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 229910052709 silver Inorganic materials 0.000 description 2
- 239000004332 silver Substances 0.000 description 2
- -1 silver ions Chemical class 0.000 description 2
- 206010020843 Hyperthermia Diseases 0.000 description 1
- FOIXSVOLVBLSDH-UHFFFAOYSA-N Silver ion Chemical compound [Ag+] FOIXSVOLVBLSDH-UHFFFAOYSA-N 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 238000000862 absorption spectrum Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000006907 apoptotic process Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000005907 cancer growth Effects 0.000 description 1
- 230000005779 cell damage Effects 0.000 description 1
- 230000030833 cell death Effects 0.000 description 1
- 208000037887 cell injury Diseases 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 239000002872 contrast media Substances 0.000 description 1
- 229940124447 delivery agent Drugs 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000002405 diagnostic procedure Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000012377 drug delivery Methods 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000036031 hyperthermia Effects 0.000 description 1
- 238000002329 infrared spectrum Methods 0.000 description 1
- 230000005291 magnetic effect Effects 0.000 description 1
- 230000003211 malignant effect Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000008204 material by function Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 230000005180 public health Effects 0.000 description 1
- 238000001959 radiotherapy Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 239000002344 surface layer Substances 0.000 description 1
- 238000002198 surface plasmon resonance spectroscopy Methods 0.000 description 1
- 231100000057 systemic toxicity Toxicity 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/0052—Thermotherapy; Hyperthermia; Magnetic induction; Induction heating therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B22—CASTING; POWDER METALLURGY
- B22F—WORKING METALLIC POWDER; MANUFACTURE OF ARTICLES FROM METALLIC POWDER; MAKING METALLIC POWDER; APPARATUS OR DEVICES SPECIALLY ADAPTED FOR METALLIC POWDER
- B22F1/00—Metallic powder; Treatment of metallic powder, e.g. to facilitate working or to improve properties
- B22F1/05—Metallic powder characterised by the size or surface area of the particles
- B22F1/054—Nanosized particles
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B22—CASTING; POWDER METALLURGY
- B22F—WORKING METALLIC POWDER; MANUFACTURE OF ARTICLES FROM METALLIC POWDER; MAKING METALLIC POWDER; APPARATUS OR DEVICES SPECIALLY ADAPTED FOR METALLIC POWDER
- B22F9/00—Making metallic powder or suspensions thereof
- B22F9/16—Making metallic powder or suspensions thereof using chemical processes
- B22F9/18—Making metallic powder or suspensions thereof using chemical processes with reduction of metal compounds
- B22F9/24—Making metallic powder or suspensions thereof using chemical processes with reduction of metal compounds starting from liquid metal compounds, e.g. solutions
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y30/00—Nanotechnology for materials or surface science, e.g. nanocomposites
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y40/00—Manufacture or treatment of nanostructures
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
Landscapes
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nanotechnology (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Crystallography & Structural Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Physics & Mathematics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Condensed Matter Physics & Semiconductors (AREA)
- Physics & Mathematics (AREA)
- Molecular Biology (AREA)
- Inorganic Chemistry (AREA)
- Medical Informatics (AREA)
- Epidemiology (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Manufacturing & Machinery (AREA)
- Composite Materials (AREA)
- Materials Engineering (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Description
Claims (7)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202011238200.2A CN112370526A (zh) | 2020-11-09 | 2020-11-09 | 一种用于癌症光热治疗的金纳米棒合成方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202011238200.2A CN112370526A (zh) | 2020-11-09 | 2020-11-09 | 一种用于癌症光热治疗的金纳米棒合成方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN112370526A true CN112370526A (zh) | 2021-02-19 |
Family
ID=74578034
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202011238200.2A Pending CN112370526A (zh) | 2020-11-09 | 2020-11-09 | 一种用于癌症光热治疗的金纳米棒合成方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN112370526A (zh) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113084191A (zh) * | 2021-04-12 | 2021-07-09 | 杭州苏铂科技有限公司 | 一种银包覆金纳米棒的制备方法 |
CN113305296A (zh) * | 2021-05-27 | 2021-08-27 | 杭州苏铂科技有限公司 | 一种激光辅助功能化金纳米棒的快速制造方法 |
CN113305297A (zh) * | 2021-05-28 | 2021-08-27 | 杭州苏铂科技有限公司 | 一种激光辅助无种子的金纳米棒合成方法 |
CN114012086A (zh) * | 2021-10-29 | 2022-02-08 | 杭州苏铂科技有限公司 | 一种聚乙二醇化金纳米棒的制备方法 |
Citations (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103624266A (zh) * | 2012-08-28 | 2014-03-12 | 北京化工大学 | 一种改变金纳米棒长径比并且降低其细胞毒性的制备方法 |
CN104001932A (zh) * | 2014-05-12 | 2014-08-27 | 中国林业科学研究院林产化学工业研究所 | 表面修饰松香基季铵盐分子的金纳米棒及其制备方法和应用 |
CN104209533A (zh) * | 2014-07-21 | 2014-12-17 | 苏州大学 | 一种快速制备金纳米棒的方法 |
CN104249158A (zh) * | 2013-06-26 | 2014-12-31 | 梁萍 | 一种大量制备金纳米棒的生长溶液 |
CN104841950A (zh) * | 2015-05-22 | 2015-08-19 | 济南大学 | 一种狗骨状金纳米晶的制备方法 |
CN104907578A (zh) * | 2015-04-29 | 2015-09-16 | 福州大学 | 一种金纳米棒的制备方法 |
CN105522163A (zh) * | 2015-11-11 | 2016-04-27 | 陕西盛迈石油有限公司 | 一种棒状金纳米粒子的制备方法 |
CN106077705A (zh) * | 2016-08-19 | 2016-11-09 | 东华大学 | 一种金纳米棒的制备方法 |
CN106267202A (zh) * | 2016-09-07 | 2017-01-04 | 厦门大学 | 具有光热/光动力治疗性能的金纳米棒复合载体及其制备 |
CN109773176A (zh) * | 2019-01-23 | 2019-05-21 | 苏州大学 | 在单波长上调制金纳米棒光学截面的方法 |
-
2020
- 2020-11-09 CN CN202011238200.2A patent/CN112370526A/zh active Pending
Patent Citations (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103624266A (zh) * | 2012-08-28 | 2014-03-12 | 北京化工大学 | 一种改变金纳米棒长径比并且降低其细胞毒性的制备方法 |
CN104249158A (zh) * | 2013-06-26 | 2014-12-31 | 梁萍 | 一种大量制备金纳米棒的生长溶液 |
CN104001932A (zh) * | 2014-05-12 | 2014-08-27 | 中国林业科学研究院林产化学工业研究所 | 表面修饰松香基季铵盐分子的金纳米棒及其制备方法和应用 |
CN104209533A (zh) * | 2014-07-21 | 2014-12-17 | 苏州大学 | 一种快速制备金纳米棒的方法 |
CN104907578A (zh) * | 2015-04-29 | 2015-09-16 | 福州大学 | 一种金纳米棒的制备方法 |
CN104841950A (zh) * | 2015-05-22 | 2015-08-19 | 济南大学 | 一种狗骨状金纳米晶的制备方法 |
CN105522163A (zh) * | 2015-11-11 | 2016-04-27 | 陕西盛迈石油有限公司 | 一种棒状金纳米粒子的制备方法 |
CN106077705A (zh) * | 2016-08-19 | 2016-11-09 | 东华大学 | 一种金纳米棒的制备方法 |
CN106267202A (zh) * | 2016-09-07 | 2017-01-04 | 厦门大学 | 具有光热/光动力治疗性能的金纳米棒复合载体及其制备 |
CN109773176A (zh) * | 2019-01-23 | 2019-05-21 | 苏州大学 | 在单波长上调制金纳米棒光学截面的方法 |
Non-Patent Citations (1)
Title |
---|
WANG, YUN等: "HCl-Retarded Gold Nanorod Growth for Aspect Ratio and Shape Tuning", 《JOURNAL OF NANOSCIENCE AND NANOTECHNOLOGY》 * |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113084191A (zh) * | 2021-04-12 | 2021-07-09 | 杭州苏铂科技有限公司 | 一种银包覆金纳米棒的制备方法 |
CN113305296A (zh) * | 2021-05-27 | 2021-08-27 | 杭州苏铂科技有限公司 | 一种激光辅助功能化金纳米棒的快速制造方法 |
CN113305297A (zh) * | 2021-05-28 | 2021-08-27 | 杭州苏铂科技有限公司 | 一种激光辅助无种子的金纳米棒合成方法 |
CN114012086A (zh) * | 2021-10-29 | 2022-02-08 | 杭州苏铂科技有限公司 | 一种聚乙二醇化金纳米棒的制备方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN112370526A (zh) | 一种用于癌症光热治疗的金纳米棒合成方法 | |
CN109396457B (zh) | 一种形状及尺寸可控的纳米金颗粒及其制备方法与应用 | |
Yu et al. | Black hollow silicon oxide nanoparticles as highly efficient photothermal agents in the second near-infrared window for in vivo cancer therapy | |
Xiao et al. | Hydrophilic bismuth sulfur nanoflower superstructures with an improved photothermal efficiency for ablation of cancer cells | |
Sun et al. | Salt-induced aggregation of gold nanoparticles for photoacoustic imaging and photothermal therapy of cancer | |
Fakayode et al. | Applications of functionalized nanomaterials in photodynamic therapy | |
Liu et al. | Photothermal therapy of Lewis lung carcinoma in mice using gold nanoshells on carboxylated polystyrene spheres | |
CN103505730B (zh) | 一种硒化铜/介孔二氧化硅核壳纳米粒子及其制备方法和应用 | |
CN106729738A (zh) | 一种枝状金铂双金属纳米粒子及其制备方法和应用 | |
CN109276542A (zh) | 一种近红外响应的碳点光热治疗试剂及其制备方法 | |
CN111978556B (zh) | 一种硒化zif-67的制备方法及应用 | |
CN108904471B (zh) | 纳米药物载体Au/MnO2及其制备方法与应用 | |
Kim et al. | Synthesis of gold nanorod-embedded polymeric nanoparticles by a nanoprecipitation method for use as photothermal agents | |
Fang et al. | Janus nanostructures formed by mesoporous silica coating Au nanorods for near-infrared chemo–photothermal therapy | |
Xing et al. | Applications of molybdenum oxide nanomaterials in the synergistic diagnosis and treatment of tumor | |
Bian et al. | Dual-template cascade synthesis of highly multi-branched Au nanoshells with ultrastrong NIR absorption and efficient photothermal therapeutic intervention | |
KR101213409B1 (ko) | 수계 분산 근적외 광열 유기 나노 입자 및 이의 제조 방법과 용도 | |
CN111214656A (zh) | 用于治疗乳腺癌的光热靶向纳米药物及其制备方法 | |
CN111686250A (zh) | 一种线粒体靶向的光热治疗剂及其制备和应用 | |
CN107961375B (zh) | 一种金属硫化物纳米材料及其制备方法和应用 | |
Zhang et al. | Constructing Cu7S4@ SiO2/DOX Multifunctional Nanoplatforms for Synergistic Photothermal–Chemotherapy on Melanoma Tumors | |
Zhou et al. | Synthesis of long gold nanorods as an efficient photothermal agent in the second near-infrared window | |
KR102398253B1 (ko) | 무기 광감응제가 도입된 이방성 플라즈모닉 입자 및 이를 포함하는 약학적 조성물 | |
CN110251482B (zh) | 一种单分散空心普鲁士蓝纳米微球、其制备方法及应用 | |
CN106902351A (zh) | 吲哚菁绿j聚集体的制备方法及应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
TA01 | Transfer of patent application right | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20220401 Address after: 310018 room 1011-1, building 15, No.57, kejiyuan Road, Baiyang street, Qiantang New District, Hangzhou City, Zhejiang Province Applicant after: Hangzhou Supo Technology Co.,Ltd. Address before: 310018 room 1011-1, building 15, No.57, kejiyuan Road, Baiyang street, Qiantang New District, Hangzhou City, Zhejiang Province Applicant before: Hangzhou Supo Technology Co.,Ltd. Applicant before: DIGONG (HANGZHOU) SCIENCE AND TECHNOLOGY INDUSTRY Co.,Ltd. |
|
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20210219 |